URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Jeanne Holden-Wiltse

Concepts (120)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Anti-HIV Agents
6
1996
182
0.430
Why?
HIV Infections
7
1996
616
0.430
Why?
Influenza A Virus, H3N2 Subtype
3
2007
61
0.410
Why?
HIV-1
6
1996
593
0.350
Why?
Orthomyxoviridae Infections
2
2010
94
0.340
Why?
Hemagglutinin Glycoproteins, Influenza Virus
2
2007
43
0.320
Why?
Food Preferences
2
1992
13
0.280
Why?
Influenza Vaccines
2
2007
269
0.260
Why?
HIV Protease Inhibitors
2
1997
58
0.260
Why?
Taste
1
1992
16
0.220
Why?
Obesity
2
1992
349
0.200
Why?
Body Weight
1
1992
337
0.200
Why?
HIV Protease
1
2010
22
0.190
Why?
Drug Resistance, Viral
1
2010
65
0.180
Why?
Spleen
1
2011
343
0.180
Why?
Delavirdine
2
1999
15
0.180
Why?
Lymphocyte Subsets
1
2009
29
0.180
Why?
Virus Replication
2
1997
307
0.180
Why?
Blood
1
2009
96
0.180
Why?
AIDS-Related Opportunistic Infections
2
1998
64
0.170
Why?
CD8-Positive T-Lymphocytes
1
2011
229
0.170
Why?
Cell Movement
1
2011
378
0.170
Why?
Influenza A virus
1
2009
218
0.150
Why?
Influenza, Human
1
2009
345
0.130
Why?
B-Lymphocytes
1
2009
479
0.130
Why?
Adult
13
1992
11572
0.120
Why?
RNA, Viral
6
1996
294
0.110
Why?
HIV Reverse Transcriptase
2
1998
129
0.100
Why?
Antiviral Agents
2
1996
170
0.100
Why?
Antiprotozoal Agents
1
2001
1
0.100
Why?
Pyrimethamine
1
2001
5
0.100
Why?
Toxoplasmosis
1
2001
7
0.100
Why?
Reverse Transcriptase Inhibitors
2
1998
93
0.100
Why?
Female
13
1992
20222
0.100
Why?
CD4 Lymphocyte Count
5
1996
160
0.100
Why?
Azithromycin
1
2001
19
0.100
Why?
Middle Aged
9
1992
10013
0.100
Why?
Encephalitis
1
2001
56
0.100
Why?
Mice, Inbred C57BL
3
2009
1700
0.090
Why?
Perylene
1
1999
1
0.090
Why?
Humans
15
1992
37165
0.080
Why?
Sarcoma, Kaposi
1
1998
15
0.080
Why?
Models, Theoretical
2
2009
194
0.080
Why?
Sesquiterpenes
1
1998
26
0.080
Why?
Piperazines
1
1998
76
0.080
Why?
Antibiotics, Antineoplastic
1
1998
49
0.080
Why?
Male
12
1992
20139
0.080
Why?
Acquired Immunodeficiency Syndrome
1
1999
201
0.080
Why?
Urea
1
1997
56
0.080
Why?
Didanosine
1
1996
21
0.070
Why?
Anti-Bacterial Agents
1
2001
442
0.070
Why?
Ribavirin
1
1996
44
0.070
Why?
Half-Life
2
1998
104
0.070
Why?
Skin Neoplasms
1
1998
230
0.060
Why?
Mice
3
2009
6206
0.060
Why?
Mutation
1
2000
1226
0.060
Why?
Drug Therapy, Combination
3
1996
397
0.060
Why?
Lung
2
2009
1148
0.060
Why?
Dietary Carbohydrates
1
1992
53
0.050
Why?
Dietary Fats
1
1992
61
0.050
Why?
Dose-Response Relationship, Drug
3
1998
1142
0.050
Why?
Animals
4
2001
16416
0.050
Why?
Models, Immunological
1
2011
62
0.050
Why?
Virology
1
2010
20
0.050
Why?
Virulence
1
2010
153
0.050
Why?
Immunoglobulin M
1
2010
150
0.050
Why?
Hong Kong
1
2009
22
0.050
Why?
Adolescent
2
1992
5044
0.050
Why?
Lymph Nodes
1
2011
215
0.050
Why?
Cross Reactions
1
2009
115
0.040
Why?
Lymphocyte Activation
1
2011
414
0.040
Why?
Drug Resistance, Microbial
2
1998
120
0.040
Why?
T-Lymphocytes, Cytotoxic
1
2010
147
0.040
Why?
HIV Core Protein p24
2
1998
33
0.040
Why?
Immunologic Memory
1
2009
129
0.040
Why?
Viral Load
2
1998
141
0.040
Why?
Enzyme-Linked Immunosorbent Assay
1
2009
472
0.040
Why?
Antibodies, Viral
1
2010
456
0.040
Why?
Immunoglobulin G
1
2010
494
0.040
Why?
Epithelial Cells
1
2010
332
0.040
Why?
Immunodiffusion
1
2007
43
0.040
Why?
Vaccines, DNA
1
2007
22
0.040
Why?
Hemagglutination Inhibition Tests
1
2007
74
0.040
Why?
Baculoviridae
1
2007
43
0.040
Why?
Disease Models, Animal
1
2011
974
0.040
Why?
Computer Simulation
1
2009
304
0.040
Why?
Predictive Value of Tests
1
2009
609
0.040
Why?
Influenza B virus
1
2007
42
0.040
Why?
Drug Administration Schedule
2
1997
374
0.040
Why?
Cohort Studies
2
1998
984
0.030
Why?
Influenza A Virus, H1N1 Subtype
1
2007
85
0.030
Why?
Double-Blind Method
1
2007
996
0.030
Why?
Models, Biological
1
2009
1029
0.030
Why?
Child
1
1992
4342
0.030
Why?
Time Factors
1
2010
3234
0.030
Why?
Toxoplasma
1
2001
6
0.030
Why?
Dermatitis, Phototoxic
1
1999
5
0.020
Why?
Injections, Intravenous
1
1999
133
0.020
Why?
Drug Eruptions
1
1998
29
0.020
Why?
Administration, Oral
1
1999
314
0.020
Why?
Zalcitabine
1
1997
7
0.020
Why?
Cyclohexanes
1
1998
19
0.020
Why?
Statistics, Nonparametric
1
1999
269
0.020
Why?
Area Under Curve
1
1998
64
0.020
Why?
Leukocytes, Mononuclear
1
1998
112
0.020
Why?
Injections, Subcutaneous
1
1997
93
0.020
Why?
Zidovudine
1
1997
71
0.020
Why?
Interferon-alpha
1
1997
85
0.020
Why?
Giant Cells
1
1996
12
0.020
Why?
Viremia
1
1996
36
0.020
Why?
Drug Interactions
1
1996
186
0.020
Why?
Genetic Variation
1
1996
147
0.020
Why?
Recombinant Proteins
1
1997
770
0.020
Why?
Molecular Sequence Data
1
2000
2046
0.020
Why?
Follow-Up Studies
1
1999
1889
0.010
Why?
Treatment Outcome
1
2001
2671
0.010
Why?
Dietary Proteins
1
1992
28
0.010
Why?
United States
1
2001
2847
0.010
Why?
Food
1
1992
32
0.010
Why?
Cells, Cultured
1
1998
2589
0.010
Why?

Visualizations


Holden-Wiltse's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department